
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Historical Deciles for [ASND] Ascendis Pharma A/S
Data updated 2024-Feb-07 (Wednesday)Compare current performance/technical metrics to history for Ascendis Pharma A/S. Range of values presented below in deciles puts current values into historical context (Up to 5-years)
Provided As-is for informational/educational purposes only and should not be construed as investment advice . Past performance may not be not indicative of future results. Always consult your Investment Adviser before any decision
Share
Use widget to view Historical Metric Deciles for other Stocks/ETFs/Indices
Summary 2024-Feb-07 Wednesday
Day Change | -1.10% Mid | Day Volatility | 2.34% Low |
Streak | ↓ 2 days Low | % Streak | -2.66% Low |
RSI | 60 Top | CCI | 113.1 Top |
MACD | -0.02 Mid | ATR | 5.04 Mid |
ADX | 30.3 Top | SSO | 83.8 Top |
Change | Volatility | % off SMA | |
---|---|---|---|
5-day | +7.20% Top | 12.15% Mid | -1.16% Mid |
10-day | +3.85% Mid | 13.29% Mid | +2.24% Mid |
20-day | +1.60% Mid | 13.29% Low | +3.12% Mid |
50-day | +51.01% Top | 60.82% Top | +12.41% Top |
100-day | +34.72% Top | 69.96% Mid | +28.69% Top |
200-day | +72.11% Top | 119.52% Top | +39.59% Top |
Choose Metric type
Select Performance timeframe above to analyze
On 2024-Feb-07, Ascendis Pharma A/S had:daily change of -1.10% intraday volatility of 2.3% 2 ↓ (down) day streak yielding -2.66% See how this compares to historical ranges below. Upto last 5 years are bucketed into deciles (click on chart line for details) with 2024-Feb-07 value annotated for comparison
Related to Ascendis Pharma A/S
Information for Ascendis Pharma A/S
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets Currently Viewing
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Sep-12 on Google
SEC Reports : Quarterly reports around 2025-Sep-12 on SEC Edgar
Compare Ascendis Pharma A/S with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Ascendis Pharma A/S
Industry : Pharmaceuticals industry performance which includes Ascendis Pharma A/S